Spots Global Cancer Trial Database for Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others
Official Title: Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others
Study ID: NCT01392222
Study Description
Brief Summary: The purpose of this study is to understand more about why some patients choose to have surgery to treat their papillary microcarcinoma (PMC) and others choose to have their papillary microcarcinoma (PMC) regularly watched by their doctor to see if and when they may need surgery (referred to as "active surveillance"). The investigators also hope learn more about what patients and their family members worry about or feel they will gain from surgery or active surveillance.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact Details
Name: Smita Banerjee, PhD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
